Today we are facing one of the worst pandemics globally. COVID-19 impacted and changed almost every aspect of our live. In healthcare industry, although some businesses had growth, most of businesses are facing challenges in negative ways. While many countries are still in an economic contraction, China has managed to control the spread of the virus and started a rapid economic recovery. In China, we have seen that the recovery on the supply side is faster than on the consumer side. In near term our healthcare industry might be facing contractions in both domestic consumption and exporting. This pandemic also brought many challenges in industrial supply chain, with a trend of technological de-collaboration and business decoupling. To overcome these challenges in the post-pandemic era, continuous innovation is the only way for healthcare business survival and prosper.
This lecture will discuss the key elements in healthcare innovation, and provide examples how Beijing Economic-Technological Development District supports innovation efforts from entrepreneurs and businesses.
Speaker: Professor Shanhong Mao, Capital Medical University
Dr. Mao is a professor and PhD supervisor (part time) at Biomedical Engineering School of Chinese Capital Medical University. He also serves Chief Counsellor and Visiting Fellow of Chinese Academy of Inspection and Quarantine Sciences. With more than 30 years of experiences in healthcare innovation and business development, Dr. Mao served as Global Head of Mfg. Science and Technology at Alcon (Novartis), and various of executive positions in fortune 500 companies e.g. Bausch&Lomb and 3M. His expertise spans pharmaceuticals, medical devices, artificial intelligence in healthcare, and material science. Dr. Mao also served as adjunct professor at UTA, there he created the “Innovation and New Product Development” course to teach UT students new product development skills encompassing healthcare market analysis and segmentation,